Literature DB >> 22219303

Serial kinetics of the antibody response against the complete Brucella melitensis ORFeome in focal vertebral brucellosis.

Anthony P Cannella1, Jennifer C Lin, Li Liang, Vidya Atluri, Eduardo Gotuzzo, Philip L Felgner, Renee M Tsolis, Joseph M Vinetz.   

Abstract

Human brucellosis is a common zoonosis worldwide. Here we present a case of focal vertebral brucellosis in a 71-year-old Mexican-American woman who contracted infection from unpasteurized goat milk. Standard agglutination serology was negative; the diagnosis was established by the isolation of Brucella melitensis from abscess fluid. A B. melitensis protein microarray comprised of nearly all proteins encoded by the bacterial genome was used to determine the kinetics of this patient's antibody responses to the complete collection of open reading frames existing in the genome (ORFeome). Three patterns of antibody responses against B. melitensis antigens were seen for serum samples obtained on days 0 (pretreatment), 14, 49, 100, and 180: (i) stable titers over time, (ii) a steady fall in titers, and (iii) an initial rise in titers followed by declining titers. Sera from this patient with chronic brucellosis recognized some of the same B. melitensis proteins as those recognized by sera from acute/subacute, blood culture-positive brucellosis patients but also recognized a distinct set of proteins. This study is the first to determine the kinetics of the human antibody responses to the complete repertoire of proteins encoded by a bacterial genome and demonstrates fundamentally different immunopathogenetic mechanisms between acute human brucellosis and chronic human brucellosis. While an extension of these findings to a larger patient population is necessary, these findings have important clinical and diagnostic implications and lead toward new insights into the fundamental immunopathogenesis of brucellosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219303      PMCID: PMC3295165          DOI: 10.1128/JCM.05298-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

Review 1.  The new global map of human brucellosis.

Authors:  Georgios Pappas; Photini Papadimitriou; Nikolaos Akritidis; Leonidas Christou; Epameinondas V Tsianos
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

Review 2.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

3.  The anergy of chronic human brucellosis.

Authors:  R D Thornes
Journal:  Ir Med J       Date:  1977-10-28

4.  An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture.

Authors:  E Gotuzzo; C Carrillo; J Guerra; L Llosa
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

5.  Selection of protective epitopes for Brucella melitensis by DNA vaccination.

Authors:  Xinghong Yang; Mary Hudson; Nancy Walters; Robert F Bargatze; David W Pascual
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Authors:  Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

7.  Generation and characterization of murine monoclonal antibodies to recombinant 26-kDa periplasmic protein of Brucella abortus.

Authors:  Sanjay Kumar; Urmil Tuteja; Harsh Vardhan Batra
Journal:  Hybridoma (Larchmt)       Date:  2007-10

8.  BrucellaCapt versus classical tests in the serological diagnosis and management of human brucellosis.

Authors:  Aurora Casanova; Javier Ariza; Manuel Rubio; Cristina Masuet; Ramón Díaz
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

Review 9.  Human brucellosis.

Authors:  María Pía Franco; Maximilian Mulder; Robert H Gilman; Henk L Smits
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

10.  Construction and evaluation of an ORFeome-based Brucella whole-genome DNA microarray.

Authors:  C Viadas; M C Rodríguez; J M García-Lobo; F J Sangari; I López-Goñi
Journal:  Microb Pathog       Date:  2009-06-12       Impact factor: 3.738

View more
  10 in total

1.  Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.

Authors:  J Xu; Y Qiu; M Cui; Y Ke; Q Zhen; X Yuan; Y Yu; X Du; J Yuan; H Song; Z Wang; G Gao; S Yu; Y Wang; L Huang; Z Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-15       Impact factor: 3.267

Review 2.  A systems biology approach for diagnostic and vaccine antigen discovery in tropical infectious diseases.

Authors:  Li Liang; Philip L Felgner
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

Review 3.  New approaches to understanding the immune response to vaccination and infection.

Authors:  David Furman; Mark M Davis
Journal:  Vaccine       Date:  2015-07-29       Impact factor: 3.641

4.  Brucella melitensis T cell epitope recognition in humans with brucellosis in Peru.

Authors:  Anthony P Cannella; Cecilia S Lindestam Arlehamn; John Sidney; Kailash P Patra; Katherine Torres; Renee M Tsolis; Li Liang; Philip L Felgner; Mayuko Saito; Eduardo Gotuzzo; Robert H Gilman; Alessandro Sette; Joseph M Vinetz
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

5.  A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosis.

Authors:  Kailash P Patra; Mayuko Saito; Vidya L Atluri; Hortensia G Rolán; Briana Young; Tobias Kerrinnes; Henk Smits; Jessica N Ricaldi; Eduardo Gotuzzo; Robert H Gilman; Renee M Tsolis; Joseph M Vinetz
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

Review 6.  The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents.

Authors:  Julia A Tree; Helen Flick-Smith; Michael J Elmore; Caroline A Rowland
Journal:  J Immunol Res       Date:  2014-09-16       Impact factor: 4.818

7.  A cohort study to define the age-specific incidence and risk factors of Shigella diarrhoeal infections in Vietnamese children: a study protocol.

Authors:  Corinne N Thompson; Katherine L Anders; Le Thi Quynh Nhi; Ha Thanh Tuyen; Pham Van Minh; Le Thi Phuong Tu; Tran Do Hoang Nhu; Nguyen Thi Thanh Nhan; Tran Thi Thao Ly; Vu Thuy Duong; Lu Lan Vi; Nguyen Thi Van Thuy; Nguyen Trong Hieu; Nguyen Vinh Van Chau; James I Campbell; Guy Thwaites; Cameron Simmons; Stephen Baker
Journal:  BMC Public Health       Date:  2014-12-17       Impact factor: 3.295

8.  Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children.

Authors:  Jiin Felgner; Aarti Jain; Rie Nakajima; Li Liang; Algis Jasinskas; Eduardo Gotuzzo; Joseph M Vinetz; Fabio Miyajima; Munir Pirmohamed; Fatimah Hassan-Hanga; Dominic Umoru; Binta Wudil Jibir; Safiya Gambo; Kudirat Olateju; Philip L Felgner; Stephen Obaro; D Huw Davies
Journal:  PLoS Negl Trop Dis       Date:  2017-06-22

9.  A foodborne outbreak of brucellosis at a police station cafeteria, Lima, Peru.

Authors:  Karina Román; Rosa Castillo; Robert H Gilman; Maritza Calderón; Aldo Vivar; Manuel Céspedes; Henk L Smits; Paolo Meléndez; Eduardo Gotuzzo; Humberto Guerra; Ryan C Maves; Michael A Matthias; Joseph M Vinetz; Mayuko Saito
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

10.  Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae.

Authors:  Christina J Maier; Richard H Maier; Dezso Peter Virok; Matthias Maass; Helmut Hintner; Johann W Bauer; Kamil Onder
Journal:  BMC Genomics       Date:  2012-11-16       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.